Viewing Study NCT00126633


Ignite Creation Date: 2025-12-25 @ 2:50 AM
Ignite Modification Date: 2026-02-10 @ 7:17 AM
Study NCT ID: NCT00126633
Status: COMPLETED
Last Update Posted: 2012-09-17
First Post: 2005-08-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine, Cisplatin, and Bevacizumab in Treating Patients With Metastatic Pancreatic Cancer
Sponsor: University of California, San Francisco
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adenocarcinoma of the pancreas View
None stage IV pancreatic cancer View